Emergent Health Corp. (EMGE) Announces New Product Introductions

KING OF PRUSSIA, Pa., Feb. 11, 2010 (GLOBE NEWSWIRE) -- Emergent Health Corp. (Pink Sheets:EMGE) (the "Company") is pleased to announce the new product introductions of Hungarest® Diet & Energy Aid as well as EmergentO2™ Water Oxygenator. Both products were scheduled for 2010 and are on target. Each product is now in stock.

Hungarest® Diet & Energy Aid is a patent-pending product with triple-action weight-loss mechanisms, energy enhancement, and with over 75 micronutrient factors that are all contained in one capsule. The Company has a preliminary site for this product in development phase for general interest purposes here: http://hungarest.info and a more advanced website is in process.

EmergentO2™ Water Oxygenator is a proprietary new approach to health and revitalization through a major low-cost water additive approach instead of shipping bulk water. Logistics as it relates to sales and marketing are under review. Distributor and sales inquiries should be directed to the Company.

The Company continues marketing its new and improved, patented Vita-Stim™ Stem Cell Nutrition product and works toward ongoing market penetration. The Vita-Stim™ product website is: http://www.vita-stim.com

Neuvitale™ Life Support, the Company's patented Physician dispensing brand for stem cell support, has also been improved. Those with distribution and sales interests in the stem cell support market should contact the Company.

Decisions are close to completion relative to new Board of Director and Scientific Advisory Board expansion with key people. The Company also continues to seek corporate and stock-trading transparency in positive ways. The patience of our shareholders is appreciated.

About Emergent Health Corp.

Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. Using patented and patent-pending, nutritionally-designed products, Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine as defined by the National Institute of Health.

Sign up for Free Newsletter Updates here: http://emergenthealth.com

This press release contains certain "forward-looking" statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the company.

This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.

CONTACT: Emergent Health Corp.
         Investor Relations
         866-427-6143
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here